Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Core Laboratories (CLB) Upsizes Common Stock Offering

Published 05/11/2016, 10:08 PM
Updated 07/09/2023, 06:31 AM

Leading oilfield services company, Core Laboratories N.V. (NYSE:CLB) , declared the pricing of the public offering of 1,475,000 shares of its common stock. This number has been raised from 1,300,000 shares of its common stock.

The stock offering, which is anticipated to close on May 17, 2016, is subject to customary closing conditions.

The shares will be offered for sale on the New York Stock Exchange or the Euronext Amsterdam from time to time in one or more transactions. The shares will either trade at negotiated prices or at the market prices at the time of sale.

Core Laboratories will provide underwriters with an option to procure up to 221,250 additional shares of its common stock within 30 days from the day of offering. This number has been raised from an initial 30-day option to purchase up to 195,000 additional shares of its common stock. Core Laboratories expects to generate gross proceeds of $175 million from the offering.

The company intends to use the proceeds from the aforesaid offering to repay a portion of the outstanding borrowings under its revolving credit facility.

The company has filed a registration statement with the Securities and Exchange Commission and the shares will be offered and sold in accordance to this statement. Also, copies of preliminary prospectus supplement relating to the offering may be collected from Credit Suisse (SIX:CSGN) Securities (USA) LLC – the sole underwriter for the offering.

Amsterdam, Netherlands-based Core Laboratories is an oilfield services company that provides reservoir management and production enhancement services to the oil and gas industry across the globe.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

For the first quarter of 2016, Core Laboratories reported adjusted diluted earnings of 37 cents per share, substantially below the year-ago quarter earnings of 85 cents per share. Reduced drilling activity levels, primarily in North America, affected the results.

Core Laboratories currently carries a Zacks Rank #4 (Sell), which implies that the stock will underperform the broader U.S. equity market over the next one to three months.

Some better-ranked players in the energy sector are Superior Drilling Products, Inc. (NYSE:SDPI) , Braskem S.A. (NYSE:BAK) and McDermott International Inc. (NYSE:MDR) . All these stocks sport a Zacks Rank #1 (Strong Buy).



MCDERMOTT INTL (MDR): Free Stock Analysis Report

CORE LABS NV (CLB): Free Stock Analysis Report

BRASKEM SA (BAK): Free Stock Analysis Report

SUPERIOR DR PRO (SDPI): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.